Cargando…

Possible role of frankincense in the treatment of benign essential blepharospasm

PURPOSE: To report two cases of benign essential blepharospasm (BEB) symptom relief in the setting of regular topical frankincense usage. OBSERVATIONS: The primary outcome measures for this report are (1) frequency of botulinum toxin (BT) injection appointments before and after the onset of regular...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Mikayla J., Harrison, Andrew R., Lee, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214279/
https://www.ncbi.nlm.nih.gov/pubmed/37252049
http://dx.doi.org/10.1016/j.ajoc.2023.101848
_version_ 1785047805633495040
author Baker, Mikayla J.
Harrison, Andrew R.
Lee, Michael S.
author_facet Baker, Mikayla J.
Harrison, Andrew R.
Lee, Michael S.
author_sort Baker, Mikayla J.
collection PubMed
description PURPOSE: To report two cases of benign essential blepharospasm (BEB) symptom relief in the setting of regular topical frankincense usage. OBSERVATIONS: The primary outcome measures for this report are (1) frequency of botulinum toxin (BT) injection appointments before and after the onset of regular frankincense usage and (2) patient report of symptoms. After starting frankincense, patient 1 decreased the frequency of her BT injection appointments from 5 to 8 months to 11+ months, eventually stopping BT injections altogether. Patient 2 decreased her BT appointments from every 3–4 months to approximately every 8 months after starting frankincense. Both patients had previously tried multiple additional treatments for their BEB symptoms which did not yield improvement; both patients reported significant improvement in their symptoms secondary to topical frankincense oil. CONCLUSION AND IMPORTANCE: Frankincense is a natural product of Boswellia trees. It has been used primarily for its anti-inflammatory properties for many years in multiple countries. We report two cases of individuals with long-standing, debilitating benign essential blepharospasm achieving significant symptom relief after beginning regular usage of topical frankincense essential oil. This natural oil offers an organic and effective treatment option for this chronic, progressive condition.
format Online
Article
Text
id pubmed-10214279
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102142792023-05-27 Possible role of frankincense in the treatment of benign essential blepharospasm Baker, Mikayla J. Harrison, Andrew R. Lee, Michael S. Am J Ophthalmol Case Rep Case Report PURPOSE: To report two cases of benign essential blepharospasm (BEB) symptom relief in the setting of regular topical frankincense usage. OBSERVATIONS: The primary outcome measures for this report are (1) frequency of botulinum toxin (BT) injection appointments before and after the onset of regular frankincense usage and (2) patient report of symptoms. After starting frankincense, patient 1 decreased the frequency of her BT injection appointments from 5 to 8 months to 11+ months, eventually stopping BT injections altogether. Patient 2 decreased her BT appointments from every 3–4 months to approximately every 8 months after starting frankincense. Both patients had previously tried multiple additional treatments for their BEB symptoms which did not yield improvement; both patients reported significant improvement in their symptoms secondary to topical frankincense oil. CONCLUSION AND IMPORTANCE: Frankincense is a natural product of Boswellia trees. It has been used primarily for its anti-inflammatory properties for many years in multiple countries. We report two cases of individuals with long-standing, debilitating benign essential blepharospasm achieving significant symptom relief after beginning regular usage of topical frankincense essential oil. This natural oil offers an organic and effective treatment option for this chronic, progressive condition. Elsevier 2023-04-11 /pmc/articles/PMC10214279/ /pubmed/37252049 http://dx.doi.org/10.1016/j.ajoc.2023.101848 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Baker, Mikayla J.
Harrison, Andrew R.
Lee, Michael S.
Possible role of frankincense in the treatment of benign essential blepharospasm
title Possible role of frankincense in the treatment of benign essential blepharospasm
title_full Possible role of frankincense in the treatment of benign essential blepharospasm
title_fullStr Possible role of frankincense in the treatment of benign essential blepharospasm
title_full_unstemmed Possible role of frankincense in the treatment of benign essential blepharospasm
title_short Possible role of frankincense in the treatment of benign essential blepharospasm
title_sort possible role of frankincense in the treatment of benign essential blepharospasm
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214279/
https://www.ncbi.nlm.nih.gov/pubmed/37252049
http://dx.doi.org/10.1016/j.ajoc.2023.101848
work_keys_str_mv AT bakermikaylaj possibleroleoffrankincenseinthetreatmentofbenignessentialblepharospasm
AT harrisonandrewr possibleroleoffrankincenseinthetreatmentofbenignessentialblepharospasm
AT leemichaels possibleroleoffrankincenseinthetreatmentofbenignessentialblepharospasm